BRD4 and Burkitt lymphoma: Lu et al. designed a heterobifunctional PROTAC, ARV-825, which can lead to efficient and prolonged degradation of BRD4 in BL cell lines by recruiting BRD4 to the E3 ubiquitin ligase Cereblon and thus downregulating the expression of MYC (Lu et al., 2015).